Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Rossoni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Supportive and Palliative Care|September 22, 2018
What's next in using CT scans to better understand cachexia?Sami Antoun, Caroline Rossoni, Emilie Lanoy
Clinical Trials (London, England)|September 21, 2019
Sequential or combined designs for Phase I/II clinical trials? A simulation studyCaroline Rossoni, Aurélie Bardet, Birgit Geoerger, et al.
Clinical Trials (London, England)|July 8, 2020
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violationRachid Abbas, Caroline Rossoni, Thomas Jaki, et al.
Nutrients|September 28, 2021
A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after <i>Helicobacter pylori</i> TherapyEric Guillemard, Marion Poirel, Florent Schäfer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2018
Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?Haitham Mirghani, Ludovic Lacroix, Caroline Rossoni, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2019
Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanomaAntoine Moya-Plana, Ruth Gabriela Herrera Gómez, Caroline Rossoni, et al.
Cancers|December 30, 2020
Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood MedulloblastomaSophie Huybrechts, Gwénaël Le Teuff, Arnault Tauziède-Espariat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
Annals of Surgical Oncology|September 13, 2020
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast LesionsCatherine Uzan, Chafika Mazouni, Caroline Rossoni, et al.
BMC Cancer|May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancerFlora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Supportive and Palliative Care|September 22, 2018
What's next in using CT scans to better understand cachexia?Sami Antoun, Caroline Rossoni, Emilie Lanoy
Clinical Trials (London, England)|September 21, 2019
Sequential or combined designs for Phase I/II clinical trials? A simulation studyCaroline Rossoni, Aurélie Bardet, Birgit Geoerger, et al.
Clinical Trials (London, England)|July 8, 2020
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violationRachid Abbas, Caroline Rossoni, Thomas Jaki, et al.
Nutrients|September 28, 2021
A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after <i>Helicobacter pylori</i> TherapyEric Guillemard, Marion Poirel, Florent Schäfer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2018
Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?Haitham Mirghani, Ludovic Lacroix, Caroline Rossoni, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2019
Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanomaAntoine Moya-Plana, Ruth Gabriela Herrera Gómez, Caroline Rossoni, et al.
Cancers|December 30, 2020
Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood MedulloblastomaSophie Huybrechts, Gwénaël Le Teuff, Arnault Tauziède-Espariat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2021
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapyIthar Gataa, Laura Mezquita, Caroline Rossoni, et al.
Annals of Surgical Oncology|September 13, 2020
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast LesionsCatherine Uzan, Chafika Mazouni, Caroline Rossoni, et al.
BMC Cancer|May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancerFlora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Pageof 2